VYOME HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-06-30 was 0.00 shares.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-03-31 was 0.00 shares.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-06-30 was 0.00 shares.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-03-31 was 0.00 shares.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 0.00 shares.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 0.00 shares.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 0.00 shares.
- VYOME HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 118.00 shares, a 99.74% decline from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-06-30 | 0.00 shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-20 | |
| 2024-12-31 | 0.00 shares 10-K · filed 2025-04-04 | |
| 2024-06-30 | 0.00 shares 10-Q · filed 2025-08-14 | |
| 2024-03-31 | 0.00 shares 10-Q · filed 2025-05-20 | |
| 2023-12-31 | 0.00 shares 10-K · filed 2025-04-04 | |
| 2022-12-31 | 0.00 shares 10-K · filed 2024-04-01 | |
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-05-12 | |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | 0.00 shares derived: sum of 4 quarters · filed 2020-11-06 |
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -1.06K shares derived: sum of 4 quarters · filed 2020-07-30 |
| 2020-03-31 | 0.00 shares 10-Q · filed 2020-06-19 | -1.06K shares derived: sum of 4 quarters · filed 2020-06-19 |
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | 118.00 shares 10-K · filed 2020-02-27 |
| 2019-09-30 | -1.06K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | 19.92K shares derived: sum of 4 quarters · filed 2019-11-08 |
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | 24.08K shares derived: sum of 4 quarters · filed 2019-07-24 |
| 2019-03-31 | 1.18K shares 10-Q · filed 2019-05-10 | 26.31K shares derived: sum of 4 quarters · filed 2019-05-10 |
| 2018-12-31 | 19.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | 45.80K shares 10-K · filed 2019-02-22 |
| 2018-09-30 | 3.10K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | 78.84K shares derived: sum of 4 quarters · filed 2018-11-02 |
| 2018-06-30 | 2.23K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 81.33K shares derived: sum of 4 quarters · filed 2018-08-02 |
| 2018-03-31 | 20.68K shares 10-Q · filed 2018-05-10 | 105.01K shares derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | 52.84K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | 84.43K shares 10-K · filed 2018-03-05 |
| 2017-09-30 | 5.59K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | 31.98K shares derived: sum of 4 quarters · filed 2017-11-03 |
| 2017-06-30 | 25.91K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | |
| 2017-03-31 | 97.00 shares 10-Q · filed 2017-05-10 | |
| 2016-12-31 | 387.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | 808.88K shares 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |